A rare nerve disorder may offer clues to potential Parkinson’s disease treatment targets, a mouse study showed. In giant…
Articles by Margarida Maia, PhD
Right Brain Bio is repurposing the approved therapy RB-190 as a treatment for Parkinson’s disease — and is…
Note: This story was updated March 17, 2025, to correct the attribution of quotes to Sonya Dumanis, PhD, deputy director…
A small Phase 1 clinical trial testing a treatment approach that uses stem cells derived from a patient’s blood cells…
The number of people with Parkinson’s disease is likely to more than double in the next years, topping 25…
A daily dose of CPL’36, an oral small molecule in the pipeline of Celon Pharma, may ease symptoms for patients…
Inserting a piece of nerve tissue from a patient’s ankle into the brain during deep brain stimulation (DBS) surgery appears…
Men with Parkinson’s disease mount stronger and more frequent immune responses than do women against PINK1, a protein that…
Thirteen blood biomarkers, including three never previously linked to Parkinson’s disease, may help in diagnosing people sooner and scientists…
A compound formed by nerve cells as they break down cholesterol appears to be involved in the formation of toxic…